0001104659-23-031929.txt : 20230313
0001104659-23-031929.hdr.sgml : 20230313
20230313204612
ACCESSION NUMBER: 0001104659-23-031929
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230309
FILED AS OF DATE: 20230313
DATE AS OF CHANGE: 20230313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NORTHSTAR BIO VENTURES, LLC
CENTRAL INDEX KEY: 0001884591
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40861
FILM NUMBER: 23728908
BUSINESS ADDRESS:
STREET 1: 117 STATE STREET, 21ST FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10004
BUSINESS PHONE: 917-267-0216
MAIL ADDRESS:
STREET 1: 117 STATE STREET, 21ST FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10004
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Monterey Innovation Acquisition Corp
CENTRAL INDEX KEY: 0001860663
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 852204842
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 17 STATE STREET
STREET 2: 21ST FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10004
BUSINESS PHONE: 917-267-0216
MAIL ADDRESS:
STREET 1: 17 STATE STREET
STREET 2: 21ST FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10004
FORMER COMPANY:
FORMER CONFORMED NAME: Monterey Bio Acquisition Corp
DATE OF NAME CHANGE: 20210505
4
1
tm239467-10_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2023-03-09
0
0001860663
Monterey Innovation Acquisition Corp
MTRY
0001884591
NORTHSTAR BIO VENTURES, LLC
C/O MONTEREY INNOVATION ACQUISITION
CORP. 17 STATE STREET, 21ST FLOOR
NEW YORK
NY
10004
0
0
1
0
Common Stock
2023-03-09
4
S
0
570000
0.006
D
1342500
D
Common Stock
2023-03-09
4
J
0
75000
A
1417500
D
This Form 4 is being filed by NorthStar Bio Ventures, LLC (the "NorthStar Co-Sponsor"). Sandip I. Patel is a manager of NorthStar Co-Sponsor. Accordingly, Mr. Patel has voting and dispositive power over the shares of common stock (the "founder shares") of Monterey Innovation Acquisition Corp. (the "Company") held by NorthStar Co-Sponsor and may be deemed to beneficially own such shares. Mr. Patel disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
In connection with the Company's previously disclosed management transition, and pursuant to share transfer agreements dated March 9, 2023, NorthStar Co-Sponsor transferred (i) 478,125 founder shares to Chardan Monterey Investments LLC and (ii) 30,625 founder shares to each of the Company's three new directors, in each case, at a price of $0.006 per share.
On March 9, 2023, Sanjeev Satyal resigned as the Company's Chief Executive Officer and, pursuant to an assignment dated March 9, 2023, transferred back to NorthStar Co-Sponsor 75,000 of the founder shares that he received from NorthStar Co-Sponsor prior to the Company's initial public offering.
NorthStar Bio Ventures, LLC By: /s/ Jason T. Simon, as Attorney-in-Fact
2023-03-13